{"result": {"id": "chatcmpl-585", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Macular Degeneration Research & Community\",\n    \"summary\": \"This report explores the interconnectedness and impact of entities within a community focused on macular degeneration research and treatment. The community comprises researchers, medical professionals, pharmaceutical companies, and patients, all working towards understanding and combating this debilitating eye disease.  The report highlights key insights into the disease's progression, treatment options, and the role of technology in advancing research.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"This community has a significant impact on individuals affected by macular degeneration, driving innovation and progress towards better treatments and preventative measures. The high level of activity and interconnectedness within this community warrants a higher rating for its overall influence.\",\n    \"findings\": [\n        {\n            \"summary\": \"Macular Degeneration: A Growing Concern\",\n            \"explanation\": \"Age-related macular degeneration (AMD) is a leading cause of vision loss worldwide, affecting millions.  The prevalence of AMD is expected to rise as the global population ages. This community plays a crucial role in understanding the disease's progression and developing effective treatments. Research efforts focus on identifying risk factors, exploring new treatment modalities, and improving diagnostic accuracy. The community also emphasizes preventative measures like healthy lifestyle choices and early detection for better outcomes.\"\n        },\n        {\n            \"summary\": \"Treatments: A Multifaceted Approach\",\n            \"explanation\": \"AMD is a complex disease with varying stages and presentations.  Treatment strategies are tailored to the specific needs of each patient. The community actively researches new therapies, including anti-VEGF drugs for wet AMD, gene therapy approaches, and innovative drug delivery systems. These advancements aim to improve vision preservation and quality of life for patients. Additionally, research focuses on developing personalized treatment plans based on individual genetic profiles and disease progression.\"\n        },\n        {\n            \"summary\": \"Technology: Revolutionizing Research & Treatment\",\n            \"explanation\": \"Technological advancements are driving significant progress in macular degeneration research and treatment.  High-resolution imaging techniques like OCT (Optical Coherence Tomography) allow for detailed retinal analysis, enabling earlier diagnosis and monitoring of disease progression. Machine learning algorithms are being used to analyze large datasets of patient data, leading to more accurate predictions and personalized treatment plans. Artificial intelligence is also playing a role in developing new drug delivery systems and optimizing existing treatments.\"\n        },\n        {\n            \"summary\": \"Collaboration: Key to Success\",\n            \"explanation\": \"The success of this community relies heavily on collaboration between researchers, medical professionals, pharmaceutical companies, and patients.  Interdisciplinary teams work together to translate research findings into clinical practice, develop new therapies, and improve patient care. This collaborative approach fosters innovation and accelerates progress in the field.\"\n        },\n        {\n            \"summary\": \"Patient Empowerment: A Vital Component\",\n            \"explanation\": \"Patients are at the heart of this community's mission.  They play a crucial role in research by participating in clinical trials, sharing their experiences, and advocating for better treatment options. Patient support groups provide valuable resources and emotional support to those affected by macular degeneration. This active involvement ensures that research efforts remain focused on addressing the needs of patients.\"\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743256964, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 676, "prompt_tokens": 2048, "total_tokens": 2724, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n1652,OPTICAL COHERENCE TOMOGRAPHY,\"Optical coherence tomography (OCT) is a medical imaging technique used to study the eye. It analyzes the structure and function of the eye, providing detailed images of the retina.  This non-invasive technique uses light waves to create cross-sectional images of the eye's layers, allowing for the diagnosis and monitoring of various eye conditions. \n\",5\n2147,PCV,A type of treatment for age-related macular degeneration,6\n1540,MNV,\"**MNV (Macular neurovascular degeneration)** is a condition that affects the macula, the central part of the retina responsible for sharp vision. It can cause vision loss and is often associated with other retinal conditions like Stargardt disease and age-related macular degeneration (AMD).  MNV is characterized by damage to the blood vessels in the macula, leading to inflammation and potential vision impairment. \n\nWhile MNV can be a rare complication of certain genetic disorders such as choroideraemia and rod-cone dystrophies, it can also occur independently. It's important to note that MNV is often diagnosed through medical examinations and follow-up assessments, particularly when the condition progresses to a more severe form known as T3 MNV (T3 Macular Neurovascular degeneration). \n\n\n**Note:** The term \"\"MNV\"\" can be used interchangeably with other terms like \"\"Myopic macular neuropathy,\"\" \"\"Myopic macular neovascularization,\"\" or \"\"Multi-nucleated virus.\"\"  \n\",19\n1623,INTRA VITREAL INJECTION,,2\n1545,PROANGIOGENIC MILIEU,The proangiogenic milieu is a biological environment that promotes blood vessel growth,1\n2224,STARGARDT DISEASE,Late-onset form of IRD,1\n2225,EXUDATIVE AGE-RELATED MACULAR DEGENERATION (AMD),A type of vision loss,1\n2226,PERIPHERALINOPATHIES,,1\n2227,ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR (ANTI-VEGF),,1\n2228,BESTROPHINOPATHIES,,1\n2229,ENHANCED S-CONE SYNDROME,,1\n3238,SE,Study area in the study,1\n3239,AXIAL LENGTH,Measurement used in the study,1\n4672,RAP,A specific type of retinal condition,1\n2979,EXUDATIVE AGE-RELATED MACULAR DEGENERATION,A type of macular degeneration,3\n538,AMD,,11\n3214,T3 MNV,\"The **T3 MNV** is a specific type of macular degeneration, also known as a type of eye disease.  It is characterized by damage to the macula, the central part of the retina responsible for sharp vision. \n\",9\n3213,DRUSEN,\"**Drusen** are small, yellowish deposits found in the macula of the eye. They can be detected by OCT images and are often associated with age-related macular degeneration (AMD).  Drusenoid changes can occur in both eyes and are a type of lesion in the eye.  They may also be present as droplet-like deposits in the eye, and their presence is linked to conditions like MNV (measles virus) affecting the eye structure. \n\",5\n2150,RECENT STUDIES,,2\n4665,MACTEL,MacTel progression in OD (stage 4),2\n1880,NEOVASCULAR AMD,A condition that causes severe vision loss,1\n248,MIR-124-3P AGOMIR,,2\n1296,CLINICAL TRIALS,Clinical trials have documented improved outcomes when combining anti-angiogenic agents and immunotherapy,4\n3216,OUTER NUCLEAR LAYER/HENLE FIBER,,1\n3217,SOFT DRUSEN,,1\n3218,OUTER RETINA,,1\n3219,INNER RETINA,,1\n3215,INSUFFICIENT PIGMENT EPITHELIAL,Part of the eye that is affected by T3 MNV,1\n223,DIABETIC RETINOPATHY,\"**Diabetic retinopathy** is a condition that affects the eyes and can lead to vision loss. It is a disease process that causes visual impairment, specifically damage to the retina.  This damage is often linked to diabetes and can be treated by targeting Kindlin-2. Research has also explored the relationship between diabetic retinopathy and age-related macular degeneration (AMD).  Diabetic retinopathy is an eye disease caused by diabetes, which can result in a range of visual impairments. \n\",3\n37,RETINA,\"The **retina** is the inner layer of the eye, located at the back. It plays a crucial role in vision by containing light-sensitive cells that convert light into electrical signals.  This part of the eye is responsible for processing and transmitting visual information to the brain. The retina is also affected by age-related macular degeneration (AMD), a leading cause of vision loss. \n\nThe **retina** is essential for vision, as it's where light enters the eye and is focused and processed before being sent to the brain.  It's also the part of the eye that needs treatment for conditions like AMD. \n\",6\n2151,SHIFT IN MANAGEMENT,,3\n4004,OCT IMAGING,A diagnostic tool for ocular conditions,4\n182,OCTA,\"The **OCTA** (Optical Coherence Tomography Angiography) technique is a method used for imaging the eye. It allows for the acquisition of images that can be used to detect various conditions, including NV (neovascularization), MNV lesions, and abnormalities such as bleeding.  OCTA is also used to examine the eye for these issues. \n\",4\n1924,FFA,\"The **FFA** (Fundus Fluorescein Angiography) is a procedure used to identify **NV** (neovascularization).  It involves injecting a fluorescent dye into the eye, allowing doctors to visualize blood vessels and detect any abnormal growth or leakage. \n\",4\n1375,CHORODIAL NEOVASCULARIZATION,\"**Choroidal neovascularization (CNV)** is a condition studied in animal models, and it serves as a model for understanding the role of FSCN1 in CNV.  It involves abnormal growth of blood vessels within the choroid, a layer of tissue at the back of the eye. This process can contribute to age-related macular degeneration (AMD), which is often associated with CNV. The description \"\"Choroidal neovascularization associated with the case\"\" provides further context by indicating its relevance to specific cases. \n\",5\n2980,FUNDUS FLUORESCENT ANGIOPLASTY,A technique used to visualize CNV lesions,3\n254,OUTER BLOOD RETINAL BARRIER (OBRB),The outer layer of the retina that regulates ion and metabolite flow,1\n2148,ANTI-VEGF MONOTHERAPY,,6\n2149,VISUAL OUTCOME,,1\n2155,CHOROIDAL MORPHOLOGY,Study of the structure of the choroid,1\n3192,DOPAMINE,\"**Dopamine** is a neurotransmitter that plays a crucial role in several bodily functions. It is involved in regulating **movement**, **attention**, **motivation**, and **reward**.  Furthermore, dopamine contributes to **mood regulation** and overall **motivation**. \n\",6\n3193,CNS,,1\n3194,TIP-CELL SPROUTING,,1\n3195,VESSEL GROWTH,,1\n3196,RETINA NEURONS,,1\n3197,CNS NEURONS,,1\n1067,PED,\"The **PED** (Pigment Epithelial Detachment) is a type of retinal disease characterized by the detachment of the pigment epithelium from the underlying tissue.  This condition can be further described as having specific characteristics related to its impact on the retina. \n\",2\n1057,BROLUCIZUMAB,\"The medication **Brolucizumab** is used for treating **neovascular AMD**, a type of age-related macular degeneration. It is also utilized in research studies and is specifically prescribed to manage **wet age-related macular degeneration**. \n\",4\n1159,NV,\"The **NV** area is an area of interest within images, and it refers specifically to the region of the eye being studied. \n\",2\n1928,NVES,NVEs stand for normal vision elsewhere,2\n2128,EXTERNAL LIMITING MEMBRANE,A membrane that limits the eye,2\n1423,RETINAL PIGMENT EPITHELIUM,\"The **retinal pigment epithelium (RPE)** is a layer of cells located within the retina of the eye. It plays a crucial role in vision, as it absorbs excess light and provides nutrients to photoreceptor cells.  This tissue is also affected by age-related macular degeneration (AMD), which can lead to vision loss. Additionally, the RPE is involved in the development of central serous retinopathy (CSR) and choroidal neovascularization (CNV). \n\",4\n1063,BRVA,Best registered visual acuity (BRVA) measurement,1\n1070,WET AGE-RELATED MACULAR DEGENERATION,,1\n1625,REAL,Real is a company or research group,4\n1626,T2,Time point in the study,1\n1627,T1,Time point in the study,1\n1643,ACTIVE CNV,\"The **ACTIVE CNV** is another type of choroidal neovascularization (CNV). It is a specific subtype of CNV. \n\",1\n1642,NONEXUDATIVE CNV,\"The **NONEXUDATIVE CNV** is a type of choroidal neovascularization (CNV). \n\",1\n1925,WFSS-OCTA VAMIS,A technique for identifying NV,1\n4010,MACHINE LEARNING,A field of study that uses computer science to analyze data,1\n4008,DME,\"**DME (Dry Age-Related Macular Degeneration)** is a condition of the eye that can be detected using Optical Coherence Tomography (OCT) images. It is an age-related eye disease that specifically affects the macula, the central part of the retina responsible for sharp vision. \n\",1\n1628,ANTI-VEGETAL THERAPY,A type of treatment for diabetic retinopathy,1\n240,DR,\"The **DR** entity refers to a disease that is currently under study.  It is also associated with Dr., which represents a person who has conducted research on this specific disease. \n\",2\n3877,LSP,A substance that was tested in the study,2\n2451,OS,\"**OS**, which stands for **osteosarcoma**, is a type of medical condition or treatment. It can also refer to the **area of the eye where vision loss occurred**.  Specifically, OS describes the **eye with drusen**, and it's the location where the diagnosis of **MNV (multifocal neuroretinopathy)** was made. \n\",2\n683,AFLIBERCEPT,\"**Aflibercept (Eylea)** is an anti-angiogenic drug that inhibits vascular endothelial growth factor (VEGF). It is approved for ocular use, specifically for the treatment of **neovascular age-related macular degeneration (nAMD)**. While its efficacy for other applications like **aproptosis** is less studied, it is known to inhibit angiogenesis, which plays a role in the development and progression of various diseases. \n\",1\n2131,EZ/RPE INTERRUPTION,,1\n3241,SECOND EYE INVOLVEMENT,,2\n3242,INCIDENCE RATE,,1\n3878,BRB,Brain region affected by DR,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n613,CNV,OPTICAL COHERENCE TOMOGRAPHY,CNV is assessed using optical coherence tomography,47\n859,PCV,MNV,PCV and MNV are both conditions that can cause vision loss,25\n589,MNV,INTRA VITREAL INJECTION,MNV lesion area was measured before and after the loading phase of intravitreal injection,21\n552,MNV,PROANGIOGENIC MILIEU,The MNV's presence in the body can affect the proangiogenic milieu,20\n904,STARGARDT DISEASE,MNV,\"MNV is a symptom of Stargardt disease\nStargardt disease can cause MNV to develop\",20\n905,EXUDATIVE AGE-RELATED MACULAR DEGENERATION (AMD),MNV,AMD may present as MNV in some cases,20\n906,MNV,PERIPHERALINOPATHIES,Peripherinopathies can develop MNV,20\n907,MNV,ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR (ANTI-VEGF),Anti-VEGF therapy can help with MNV in some cases,20\n908,MNV,BESTROPHINOPATHIES,Bestrophinopathies tend to develop MNV early on,20\n909,MNV,ENHANCED S-CONE SYNDROME,Enhanced S-cone syndrome can cause type 3 MNV,20\n1348,MNV,SE,Macular neuropathy was measured in the study area SE,20\n1349,MNV,AXIAL LENGTH,Macular neuropathy was measured in the study area axial length,20\n2016,MNV,RAP,MNV is a specific type of RAP,20\n1233,EXUDATIVE AGE-RELATED MACULAR DEGENERATION,AMD,Exudative AMD is a type of AMD,14\n1334,T3 MNV,DRUSEN,\"**T3 MNV**, also known as **\"\"macular neuroretinopathy\"\"**, is a type of macular degeneration.  It is characterized by the presence of **drusen**, which are fatty deposits under the retina, and often originates above these soft drusen. Notably, T3 MNV has been linked to the progressive growth of drusen over time. \n\",14\n868,AMD,RECENT STUDIES,Recent studies support the use of PCV for AMD,13\n2017,AMD,MACTEL,AMD and MacTel are both types of eye diseases,13\n865,AMD,NEOVASCULAR AMD,AMD and neovascular AMD are related,12\n67,RETINAL NEOVASCULARIZATION,MIR-124-3P AGOMIR,Attenuated pathological retinal neovascularization in OIR mice,10\n862,PCV,CLINICAL TRIALS,Clinical trials have shown that PCV is effective for treating AMD,10\n1333,DRUSEN,OPTICAL COHERENCE TOMOGRAPHY,Drusen are measured using optical coherence tomography,10\n1335,T3 MNV,OUTER NUCLEAR LAYER/HENLE FIBER,T3 MNV was associated with thinning of the outer nuclear layer and Henle fiber,10\n1337,T3 MNV,SOFT DRUSEN,T3 MNV was associated with soft drusen,10\n1338,T3 MNV,OUTER RETINA,T3 MNV affected the outer retina,10\n1339,T3 MNV,INNER RETINA,T3 MNV affected the inner retina,10\n1340,T3 MNV,INSUFFICIENT PIGMENT EPITHELIAL,T3 MNV was associated with insufficient pigment epithelium,10\n74,DIABETIC RETINOPATHY,RETINA,Diabetic retinopathy affects the retina,9\n863,PCV,SHIFT IN MANAGEMENT,\"Over the past decade, there has been a shift in how PCV is managed\",9\n1767,OCT IMAGING,DRUSEN,OCT imaging can be used to detect drusen,9\n73,RETINA,MIR-124-3P AGOMIR,Attenuated pathological retinal neovascularization in OIR mice,8\n725,OCTA,FFA,OCTA is superior to FFA in terms of the number of NVEs identified,8\n1229,CHORODIAL NEOVASCULARIZATION,EXUDATIVE AGE-RELATED MACULAR DEGENERATION,CNV is a factor in the pathophysiology and prognosis of AMD,8\n1235,FUNDUS FLUORESCENT ANGIOPLASTY,OPTICAL COHERENCE TOMOGRAPHY,Both techniques are used to visualize CNV lesions,8\n75,RETINA,OUTER BLOOD RETINAL BARRIER (OBRB),The oBRB regulates ion and metabolite flow into the retina,7\n870,ANTI-VEGF MONOTHERAPY,VISUAL OUTCOME,Anti-VEGF monotherapy can improve visual outcomes in patients with AMD,7\n874,PCV,CHOROIDAL MORPHOLOGY,Personalized therapy for patients with Polycythemia Vera is guided by the study of choroidal morphology,7\n1327,DOPAMINE,CNS,Dopamine restricts vascular development in the CNS,7\n1328,DOPAMINE,TIP-CELL SPROUTING,Dopamine inhibits tip-cell sprouting and vessel growth,7\n1329,DOPAMINE,VESSEL GROWTH,Dopamine reduces vessel growth,7\n1330,DOPAMINE,RETINA NEURONS,Dopamine production by retina neurons is limited,7\n1331,DOPAMINE,CNS NEURONS,Dopamine production by CNS neurons is elevated,7\n404,PED,BROLUCIZUMAB,The PED volume improved after switching to brolucizumab,6\n726,OCTA,NV,OCTA can detect NV with high accuracy,6\n727,OCTA,NVES,OCTA identified more NVEs than FFA,6\n840,EXTERNAL LIMITING MEMBRANE,RETINAL PIGMENT EPITHELIUM,\"The **external limiting membrane** and **retinal pigment epithelium** are both components of the eye.  They are distinct structures that play specific roles within the eye's structure and function. The external limiting membrane is a layer found on the outer surface of the retina, while the retinal pigment epithelium (RPE) lies beneath the photoreceptor cells in the retina. Both structures are essential for proper vision. Notably, disruptions to these components have been observed in certain conditions like T3 MNV (a viral infection).  \n\",6\n401,BROLUCIZUMAB,BRVA,\"Brolucizumab is a medication used to treat BRVA, which measures visual acuity in patients with wet age-related macular degeneration\",5\n403,BROLUCIZUMAB,WET AGE-RELATED MACULAR DEGENERATION,Brolucizumab is a medication used to treat wet age-related macular degeneration,5\n591,REAL,T2,Real conducted a study with T2 as a time point,5\n592,REAL,T1,Real conducted a study with T1 as a time point,5\n617,RETINAL PIGMENT EPITHELIUM,ACTIVE CNV,Active CNV affected the retinal pigment epithelium,5\n618,RETINAL PIGMENT EPITHELIUM,NONEXUDATIVE CNV,Nonexudative CNV did not affect the retinal pigment epithelium,5\n723,FFA,WFSS-OCTA VAMIS,FFA and wfSS-OCTA VAMIs are used to identify NV,5\n1766,MACHINE LEARNING,OCT IMAGING,\"Machine learning algorithms are used in conjunction with OCT imaging for improved detection and management of drusen, CNV, and DME\",5\n1769,OCT IMAGING,DME,OCT imaging can be used to detect DME,5\n595,ANTI-VEGETAL THERAPY,DIABETIC RETINOPATHY,Anti-VEGF therapy is used to treat diabetic retinopathy,4\n1688,DR,LSP,DR is a condition that LSP can ameliorate,4\n2015,OS,PED,The OS is the part of the eye where the PED is located,4\n590,AFLIBERCEPT,INTRA VITREAL INJECTION,Drug used in intravitreal injection,3\n841,EXTERNAL LIMITING MEMBRANE,EZ/RPE INTERRUPTION,External limiting membrane and EZ/RPE interruption are related to PM-MNV activity),3\n1352,SECOND EYE INVOLVEMENT,INCIDENCE RATE,Incidence of second eye involvement after onset of MNV,3\n1687,BRB,LSP,LSP inhibits inflammation and angiogenesis to improve BRB function,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_fb11ad6a60f8d9b667a8f862a2e78e3d0e1d5ffbd9566aadda17b8e599cb07b4_v2"}